首页> 外文期刊>Nature >The histone chaperone CAF-1 safeguards somatic cell identity
【24h】

The histone chaperone CAF-1 safeguards somatic cell identity

机译:组蛋白伴侣CAF-1维护体细胞身份

获取原文
获取原文并翻译 | 示例
       

摘要

Cellular differentiation involves profound remodelling of chromatic landscapes, yet the mechanisms by which somatic cell identity is subsequently maintained remain incompletely understood. To further elucidate regulatory pathways that safeguard the somatic state, we performed two comprehensive RNA interference (RNAi) screens targeting chromatin factors during transcription-factor-mediated reprogramming of mouse fibroblasts to induced pluripotent stem cells (iPS cells). Subunits of the chromatin assembly factor-1 (CAF-1) complex, including Chaf1a and Chaf1b, emerged as the most prominent hits from both screens, followed by modulators of lysine sumoylation and heterochromatin maintenance. Optimal modulation of both CAF-1 and transcription factor levels increased reprogramming efficiency by several orders of magnitude and facilitated iPS cell formation in as little as 4 days. Mechanistically, CAF-1 suppression led to a more accessible chromatin structure at enhancer elements early during reprogramming. These changes were accompanied by a decrease in somatic heterochromatin domains, increased binding of Sox2 to pluripotency-specific targets and activation of associated genes. Notably, suppression of CAF-1 also enhanced the direct conversion of B cells into macrophages and fibroblasts into neurons. Together, our findings reveal the histone chaperone CAF-1 to be a novel regulator of somatic cell identity during transcription-factor-induced cell-fate transitions and provide a potential strategy to modulate cellular plasticity in a regenerative setting.
机译:细胞分化涉及色域的深刻重塑,但随后仍未完全理解维持体细胞同一性的机制。为了进一步阐明维护体细胞状态的调控途径,我们在转录因子介导的小鼠成纤维细胞重编程为诱导多能干细胞(iPS细胞)过程中,针对染色质因子进行了两次全面的RNA干扰(RNAi)筛选。染色质组装因子-1(CAF-1)复合体的亚基,包括Chaf1a和Chaf1b,在两个屏幕上均以最突出的命中出现,其次是赖氨酸sumoylation和异染色质维持的调节剂。 CAF-1和转录因子水平的最佳调节将重编程效率提高了几个数量级,并在短短4天内促进了iPS细胞的形成。从机理上讲,CAF-1抑制在重编程早期导致增强子元件上的染色质结构更易于访问。这些变化伴随着体细胞异染色质域的减少,Sox2与多能性特异性靶标的结合增加以及相关基因的激活。值得注意的是,对CAF-1的抑制还增强了B细胞直接转化为巨噬细胞和成纤维细胞转化为神经元的能力。在一起,我们的发现揭示了组蛋白伴侣CAF-1是转录因子诱导的细胞命运转变过程中体细胞身份的新型调节剂,并提供了在再生环境中调节细胞可塑性的潜在策略。

著录项

  • 来源
    《Nature》 |2015年第7581期|218-224|共7页
  • 作者单位

    Massachusetts Gen Hosp, Ctr Canc, Dept Mol Biol, Boston, MA 02114 USA|Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA|Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA|Harvard Stem Cell Inst, Cambridge, MA 02138 USA|Howard Hughes Med Inst, Chevy Chase, MD 20815 USA;

    Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna Bioctr VBC, A-1030 Vienna, Austria;

    Res Inst Mol Pathol IMP, Vienna Bioctr VBC, A-1030 Vienna, Austria;

    Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02115 USA|Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA;

    Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA|Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA;

    CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA;

    Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna Bioctr VBC, A-1030 Vienna, Austria;

    Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA|Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA;

    Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA|Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA;

    Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA|Harvard Stem Cell Inst, Cambridge, MA 02138 USA|Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA;

    Massachusetts Gen Hosp, Ctr Canc, Dept Mol Biol, Boston, MA 02114 USA|Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA|Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA|Harvard Stem Cell Inst, Cambridge, MA 02138 USA|Howard Hughes Med Inst, Chevy Chase, MD 20815 USA;

    Massachusetts Gen Hosp, Ctr Canc, Dept Mol Biol, Boston, MA 02114 USA|Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA|Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA|Harvard Stem Cell Inst, Cambridge, MA 02138 USA|Howard Hughes Med Inst, Chevy Chase, MD 20815 USA;

    Massachusetts Gen Hosp, Ctr Canc, Dept Mol Biol, Boston, MA 02114 USA|Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA|Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA|Harvard Stem Cell Inst, Cambridge, MA 02138 USA|Howard Hughes Med Inst, Chevy Chase, MD 20815 USA;

    Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA;

    Massachusetts Gen Hosp, Ctr Canc, Dept Mol Biol, Boston, MA 02114 USA|Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA|Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA|Harvard Stem Cell Inst, Cambridge, MA 02138 USA|Howard Hughes Med Inst, Chevy Chase, MD 20815 USA;

    Res Inst Mol Pathol IMP, Vienna Bioctr VBC, A-1030 Vienna, Austria;

    Res Inst Mol Pathol IMP, Vienna Bioctr VBC, A-1030 Vienna, Austria;

    Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02115 USA|Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA;

    Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA|Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA;

    Res Inst Mol Pathol IMP, Vienna Bioctr VBC, A-1030 Vienna, Austria;

    Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna Bioctr VBC, A-1030 Vienna, Austria;

    Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna Bioctr VBC, A-1030 Vienna, Austria;

    NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med,Dept Cel, New York, NY 10016 USA;

    Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna Bioctr VBC, A-1030 Vienna, Austria;

    NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med,Dept Cel, New York, NY 10016 USA;

    Howard Hughes Med Inst, Chevy Chase, MD 20815 USA|Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA|Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA;

    Inst Curie, Ctr Rech, F-75248 Paris, France;

    Howard Hughes Med Inst, Chevy Chase, MD 20815 USA|Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA;

    Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA|Harvard Stem Cell Inst, Cambridge, MA 02138 USA|Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA;

    Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA|Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA;

    CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA;

    Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA|Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA;

    Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02115 USA|Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA;

    Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna Bioctr VBC, A-1030 Vienna, Austria;

    Res Inst Mol Pathol IMP, Vienna Bioctr VBC, A-1030 Vienna, Austria;

    Massachusetts Gen Hosp, Ctr Canc, Dept Mol Biol, Boston, MA 02114 USA|Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA|Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA|Harvard Stem Cell Inst, Cambridge, MA 02138 USA|Howard Hughes Med Inst, Chevy Chase, MD 20815 USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号